ArticleInternational journal of radiation oncology, biology, physics2026
Musculoskeletal and Marrow Sparing With Proton FLASH Radiation Therapy in Juvenile Mice.
Article in International journal of radiation oncology, biology, physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
13 authors.
Funding
Abstract
purposeRadiation‑induced musculoskeletal toxicities are one of the major limitations in pediatric patients whose skeletons are still developing. FLASH radiation therapy, delivered at ultrahigh dose rates (>40 Gy/s), has demonstrated normal-tissue sparing in preclinical models, but its effects on the developing skeleton and marrow remain incompletely characterized. This study evaluated the normal-tissue effects 10 weeks after proton FLASH irradiation in juvenile mice, modeling the pediatric context. METHODS AND MATERIALS: Juvenile C57BL/6 mice (3 to 4 weeks old) were randomized to receive 11 Gy protons with FLASH (≈200 Gy/s), conventional dose-rate irradiation (CONV, 0.2 Gy/s average), or sham treatment (SHAM) to the left hind leg using a synchrotron-based proton beamline. Mice were followed for 10 weeks posttreatment. Bone toxicity was assessed with micro-computed tomography, including bone mineral density, bone volume fraction, trabecular indices, and limb length. Bone marrow cellularity was quantified on hematoxylin and eosin-stained sections, and muscle fibrosis was assessed using Masson's trichrome staining.
resultsProton FLASH irradiation preserved bone microarchitecture compared with conventional irradiation, with higher bone mineral density and bone volume fractions (P < .05). Trabecular number was maintained, while the structure model index indicated a mechanically favorable trabecular structure in the FLASH group. Proton FLASH also partially preserved longitudinal bone growth, with tibial length ratios of 0.94 (FLASH) versus 0.91 (CONV) versus 1.00 (SHAM). Bone marrow cellularity was preserved in FLASH mice (5.3% reduction vs SHAM) compared with CONV (11.3% reduction; P < .05). Muscle fibrosis was significantly lower in the FLASH group (fibrosis positivity 2.6% vs 3.0% for FLASH vs CONV; P < .05). No severe immobility or weight loss was observed across groups.
conclusionsProton FLASH reduced musculoskeletal and marrow toxicities at 10 weeks postirradiation in juvenile mice. These findings extend prior proton FLASH adult mice studies by demonstrating tissue sparing in a juvenile model and support further investigation of FLASH as a strategy to reduce normal‑tissue injury during radiation therapy of pediatric patients.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.